2022 Medical Innovation and Development International Conference was held in Yantai

Qilu.com · Lightning News, August 18th. On the morning of August 18, 2022 Medical Innovation and Development International Conference was held at the Baying Bay International Conference Center in Yantai. The theme of this conference is "Innovation, Opportunities, Development, and Win -win". It comes from about 290 people from leaders, academicians, and well -known entrepreneurs from relevant national ministries and commissions. This is also the fifth consecutive international meeting of Yantai. The conference will hold high -level theme conferences, professional branches and on -site observation, and promote the Biopharmaceutical Industrial Park of the Mouping District, the Yellow Bohai New District Biomedical Industrial Park and Yantai City's industrial policy and development environment.

At present, there are 127 companies in Yantai Biomedical Industry Chain, with 55 companies with sales revenue exceeding 100 million yuan, 13 companies with more than one billion yuan, 3 national specialty new giant companies, 9 gazelle companies, and provincial manufacturing industry There are 4 single championships and 11 special "major new drug creation" in the country. The level of innovation is leading in China. Yantai has 651 drug approved numbers, and focuses on 46 medicines, including innovative products such as Tianyouli, Energy, Sodium Sodium, Eur Thai, and Micro balls, transparent medicine, lipid body technology , Oral repair membrane, high -pressure oxygen cabin, biopharmaceutical CDMO and other technologies have domestic leading levels. Last year, Yantai's world's first double -target therapy to treat systemic lupus erythematosus "Thai Sip", China's first self -developed ADC new biosome "Vidici Micide", and the first self -developed independently developed in China The second -generation anti -psychiatric long -acting needle "injecting Ripidone Micro Sin (Ⅱ)" was approved to be listed.

At the same time, based on the industrial foundation, Yantai established the city's "1+3+X" biomedical industry space layout, that is, the core areas of life science innovation of Muping District and high -tech zones as the leading construction park, and jointly develop the development demonstration zone of the health integration and development of the western region The centralized development demonstration zone of life and health of the central region and the green bearing area of ​​high -end raw materials in the southern part of the southern part, simultaneously promote the coordinated development of several characteristic parks. The planned area of ​​the Link Construction Park is 23.6 square kilometers. At present, it is concentrated in the concentration of advantageous resources to create the Yantai Blue Medicine Valley Life Island Park.

In the next step, Yantai will focus on accelerating the construction of key projects, strengthening precision investment promotion, strengthening the construction of professional park carriers, focusing on the advantages areas to carry out the entire industrial chain layout, continuously enhance the core competitiveness of the biomedical industry, and move towards the top field of biomedicine.